Yuzhou Shen

669 total citations
21 papers, 507 citations indexed

About

Yuzhou Shen is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yuzhou Shen has authored 21 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yuzhou Shen's work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (5 papers) and RNA modifications and cancer (3 papers). Yuzhou Shen is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (5 papers) and RNA modifications and cancer (3 papers). Yuzhou Shen collaborates with scholars based in China, Taiwan and Australia. Yuzhou Shen's co-authors include Xufeng Pan, Jicheng Tantai, Wentao Li, Yong Chen, Heng Zhao, Xiaoguang Wang, Jianyu Gong, Yanrong Zhang, Aimal Khan and Chunyu Ji and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and International Journal of Hydrogen Energy.

In The Last Decade

Yuzhou Shen

21 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuzhou Shen China 10 229 121 87 71 67 21 507
Yaodong Chen China 16 356 1.6× 131 1.1× 113 1.3× 130 1.8× 52 0.8× 35 715
Guoqing Zuo China 14 181 0.8× 125 1.0× 38 0.4× 73 1.0× 78 1.2× 36 577
Eleana Hatzidaki Greece 11 205 0.9× 117 1.0× 77 0.9× 58 0.8× 32 0.5× 21 582
Qingzhu Yang China 12 211 0.9× 147 1.2× 55 0.6× 62 0.9× 24 0.4× 19 471
Mingming Lv China 14 310 1.4× 62 0.5× 61 0.7× 30 0.4× 35 0.5× 25 654
Xiaolan Guo China 15 207 0.9× 47 0.4× 169 1.9× 71 1.0× 66 1.0× 46 668
Xinxin Tian China 15 297 1.3× 186 1.5× 42 0.5× 81 1.1× 33 0.5× 33 614
Bolin Yang China 16 271 1.2× 173 1.4× 128 1.5× 92 1.3× 64 1.0× 52 767
Xiaochen Liu China 14 277 1.2× 80 0.7× 49 0.6× 41 0.6× 25 0.4× 40 708

Countries citing papers authored by Yuzhou Shen

Since Specialization
Citations

This map shows the geographic impact of Yuzhou Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuzhou Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuzhou Shen more than expected).

Fields of papers citing papers by Yuzhou Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuzhou Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuzhou Shen. The network helps show where Yuzhou Shen may publish in the future.

Co-authorship network of co-authors of Yuzhou Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Yuzhou Shen. A scholar is included among the top collaborators of Yuzhou Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuzhou Shen. Yuzhou Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Xiaoyan, et al.. (2024). Suv39h1 contributes to activation of hepatic stellate cells in non-alcoholic fatty liver disease by enabling anaerobic glycolysis. Life Sciences. 341. 122498–122498. 8 indexed citations
2.
Li, Shilin, et al.. (2024). Exploring the prognostic and diagnostic value of lactylation-related genes in sepsis. Scientific Reports. 14(1). 23130–23130. 8 indexed citations
3.
Li, Yong-Jie, Hao Xu, Qiaolong Yuan, et al.. (2023). Study on Deformation Force of Hard Aluminum Alloy Incremental Forming. Coatings. 13(3). 571–571. 4 indexed citations
5.
Li, Yong-Jie, Hongyu Wei, Jizhou Kong, et al.. (2023). Hydrogen adsorption and diffusion on the surface of alloyed steel: First-principles studies. International Journal of Hydrogen Energy. 54. 1478–1486. 22 indexed citations
6.
Li, Shilin, et al.. (2022). Mechanisms of Panax Ginseng on Treating Sepsis by RNA-Seq Technology. Infection and Drug Resistance. Volume 15. 7667–7678. 11 indexed citations
7.
Tantai, Jicheng, Xufeng Pan, Yong Chen, Yuzhou Shen, & Chunyu Ji. (2022). TRIM46 activates AKT/HK2 signaling by modifying PHLPP2 ubiquitylation to promote glycolysis and chemoresistance of lung cancer cells. Cell Death and Disease. 13(3). 285–285. 44 indexed citations
8.
Hu, Tao, et al.. (2022). The Role of Praziquantel in the Prevention and Treatment of Fibrosis Associated with Schistosomiasis: A Review. Journal of Tropical Medicine. 2022. 1–8. 9 indexed citations
9.
Shen, Yuzhou, et al.. (2022). Oridonin-loaded lipid-coated calcium phosphate nanoparticles: preparation, characterization, and application in A549 lung cancer. Pharmaceutical Development and Technology. 27(5). 598–605. 13 indexed citations
10.
Tantai, Jicheng, Xufeng Pan, Yong Chen, Yuzhou Shen, & Chunyu Ji. (2020). Inhibition of TRIM46 Suppresses Lung Adenocarcinoma Growth by Promoting DUOX2-Mediated Reactive Oxygen Species Production. SSRN Electronic Journal. 1 indexed citations
11.
Shen, Yuzhou & Jicheng Tantai. (2020). <p>Co-Delivery Anticancer Drug Nanoparticles for Synergistic Therapy Against Lung Cancer Cells</p>. Drug Design Development and Therapy. Volume 14. 4503–4510. 24 indexed citations
12.
13.
Shen, Yuzhou, et al.. (2019). Gene regulation and prognostic indicators of lung squamous cell carcinoma: TCGA‐derived miRNA/mRNA sequencing and DNA methylation data. Journal of Cellular Physiology. 234(12). 22896–22910. 8 indexed citations
14.
Pan, Xufeng, Yong Chen, Yuzhou Shen, & Jicheng Tantai. (2019). Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7. Cell Death and Disease. 10(6). 429–429. 122 indexed citations
15.
Shen, Yuzhou & Wentao Li. (2018). HA/HSA co-modified erlotinib&ndash;albumin nanoparticles for lung cancer treatment. Drug Design Development and Therapy. Volume 12. 2285–2292. 62 indexed citations
16.
Shen, Yuzhou, et al.. (2018). Synthesis of Z-scheme g-C3N4/Ag/Ag3PO4 composite for enhanced photocatalytic degradation of phenol and selective oxidation of gaseous isopropanol. Materials Research Bulletin. 107. 407–415. 60 indexed citations
18.
Jiang, Wenyang, Rui Wang, Xufeng Pan, et al.. (2016). Clinicopathological features and prognosis of primary pulmonary lymphoepithelioma-like carcinoma. Journal of Thoracic Disease. 8(9). 2610–2616. 46 indexed citations
19.
Shen, Yuzhou, Xufeng Pan, & Heng Zhao. (2014). The histone demethylase PHF8 is an oncogenic protein in human non-small cell lung cancer. Biochemical and Biophysical Research Communications. 451(1). 119–125. 43 indexed citations
20.
Tantai, Jicheng, Yuzhou Shen, & Heng Zhao. (2013). Quantitative assessment of the influence of common variations on 6p21 and lung cancer risk. Tumor Biology. 35(1). 689–694. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026